PVA/Chitosan Nanofibers Loaded with Colchicine and SDC: Overcoming Drug Resistance in Breast Cancer
PVA/Chitosan Nanofibers Loaded with Colchicine and SDC: Overcoming Drug Resistance in Breast Cancer
Arash Kamyab1 Hamed Morad2 Hamed Montazeri3 Zohreh Mohammadi4 Mohammadreza Shirazi5
1) M.Sc. Student in Pharmaceutics, Pharmaceutics and Pharmaceutical Nanotechnology, Iran University of Medical Sciences (IUMS), Tehran, Iran,
2) Assistant Professor, Department of Pharmaceutics and Pharmaceutical Nanotechnology, Iran University of Medical Sciences (IUMS), Tehran, Iran,
3) Associate Professor, Department of Pharmacognosy - Biotechnology, Iran University of Medical Sciences (IUMS), Tehran, Iran,
4) Associate Professor, Department of Pharmaceutics and Pharmaceutical Nanotechnology, Iran University of Medical Sciences (IUMS), Tehran, Iran,
5) Ph.D. Student in Chemical Engineering, Biotechnology, Babol Noshirvani University of Technology (BNUT), Babol, Iran,
IOI Code
:
AAGF-AAHGDA
Publication :
9th International Conference on Applied Researches in Science & Engineering (carseconf.com/9th)
Abstract :
Breast cancer (BC), the most prevalent malignancy in women, continues to face the significant challenge of multidrug resistance (MDR), which is primarily driven by the active efflux of cytotoxic drugs via the P-glycoprotein (P-gp) pump. The potent anti-cancer agent, Colchicine (COL), which destabilizes microtubules, exhibits limited efficacy in resistant cells due to its classification as a P-gp substrate. The main objective of this research is to engineer a biocompatible composite nanofiber platform utilizing Polyvinyl Alcohol (PVA) and Chitosan (CS) for the co-delivery of COL and Sodium Deoxycholate (SDC). The methodology involves using the electrospinning technique to fabricate nanofibers with a high surface-to-volume ratio and controlled release characteristics. SDC, a biocompatible bile salt, acts as a penetration enhancer and probable MDR modulator, boosting the intracellular accumulation of COL by increasing membrane permeability and partially inhibiting P-gp activity. The results summarize that these ternary nanofibers (PVA/CS/COL/SDC) have been successfully engineered and are expected to demonstrate a potent synergistic effect in inhibiting the growth of MCF-7 breast cancer cells by effectively reversing MDR and allowing for the use of reduced toxic doses. This strategy provides the potential to maximize the therapeutic utility of COL in drug-resistant tumors.
Keywords : breast cancer multidrug resistance (mdr) p glycoprotein (p gp) nanofiber colchicine (col) sodium deoxycholate (sdc) electrospinning